Moderna, Inc.: Moderna Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Business Updates

Q4 2021 revenues of $7.2 billion; GAAP net-income of $4.9 billion and GAAP diluted EPS of $11.29Full year 2021 revenues of $18.5 billion; GAAP net-income of $12.2 billion and GAAP diluted EPS of $28.29Moderna

Related Keywords

Puerto Rico ,Norway ,Malaysia ,Australia ,Taiwan ,Japan ,United States ,Hong Kong ,United Kingdom ,Madrid ,Spain ,Canada ,Bancel ,Rhôalpes ,France ,Germany ,Bangladesh ,India ,Netherlands ,Denmark ,Kuwait ,Singapore ,Belgium ,Italy ,Sweden ,Cambridge ,Cambridgeshire ,South Korea ,Poland ,Switzerland ,American ,Lavina Talukdar ,Intratumoral Immuno ,Juan Andres ,Asia Pacific ,Colleen Hussey ,Noubar Afeyan ,Us Department Of Defense ,Research Development ,Nasdaq ,Development Expenses ,Astrazeneca ,Moderna Inc ,Vertex Pharmaceuticals ,Company Recognition ,Summary Of Program ,Institute For Life Changing Medicines ,National Institutes Of Health ,World Health Organization ,Artificial Intelligence Ai Academy ,Drug Administration ,Exchange Commission ,Vaccine Development ,Share Repurchase Program ,American Heart Association Scientific Sessions ,Melinda Gates Foundation ,Ai Academy ,Thermo Fisher ,National Academy Of Engineering ,European Union ,Vaccine Research Center ,Carnegie Mellon University ,Moderna Charitable Foundation ,Vaccine Initiative ,Corporate Communications ,European Medicines Agency ,Health Canada ,Therapeutic Goods Administration ,Chief Executive Officer ,Goods Administration ,Biologics License Application ,Propionic Acidemia ,Methylmalonic Acidemia ,Program Highlights ,Receptor Binding Domain ,N Terminal Domain ,Fast Track ,National Institutes ,Research Center ,Cell Surface Therapeutics ,Regenerative Therapeutics ,Astrazeneca Led Phase ,American Heart Association ,Scientific Sessions ,Intracellular Therapeutics ,Drug Designation ,Najjar Syndrome Type ,Crigler Najjar Syndrome Type ,Rare Pediatric Disease ,Life Changing Medicines ,Full Year ,Administrative Expenses ,Income Taxes ,Per Share ,Cash Provided ,Operating Activities ,Purchase Agreements ,Effective Tax Rate ,Repurchase Program ,Charitable Foundation ,Manufacturing Partnerships ,Artificial Intelligence ,Science Careers ,Andres Elected ,National Academy ,Chief Technical Operations ,Quality Officer ,Moderna Annual Meeting ,Analyst Event ,Private Securities Litigation Reform Act ,Annual Report ,Vice President ,Infect Dis Now ,Moderna ,Reports ,Fourth ,Quarter ,Iscal ,Ear ,021 ,Financial ,Results ,Rovides ,Business ,Updates ,